Harnessing the Power of Our Immune System: The Antimicrobial and Antibiofilm Properties of Nitric Oxide
- PMID: 39770746
- PMCID: PMC11677572
- DOI: 10.3390/microorganisms12122543
Harnessing the Power of Our Immune System: The Antimicrobial and Antibiofilm Properties of Nitric Oxide
Abstract
Nitric oxide (NO) is a free radical of the human innate immune response to invading pathogens. NO, produced by nitric oxide synthases (NOSs), is used by the immune system to kill microorganisms encapsulated within phagosomes via protein and DNA disruption. Owing to its ability to disperse biofilm-bound microorganisms, penetrate the biofilm matrix, and act as a signal molecule, NO may also be effective as an antibiofilm agent. NO can be considered an underappreciated antimicrobial that could be levied against infected, at-risk, and hard-to-heal wounds due to the inherent lack of bacterial resistance, and tolerance by human tissues. NO produced within a wound dressing may be an effective method of disrupting biofilms and killing microorganisms in hard-to-heal wounds such as diabetic foot ulcers, venous leg ulcers, and pressure injuries. We have conducted a narrative review of the evidence underlying the key antimicrobial and antibiofilm mechanisms of action of NO for it to serve as an exogenously-produced antimicrobial agent in dressings used in the treatment of hard-to-heal wounds.
Keywords: antimicrobial; biofilm; hard-to-heal; nitric oxide; wound.
Conflict of interest statement
Jonathan Matthew Roberts, Scarlet Milo, and Daniel Gary Metcalf declare employment and stock/stock options from Convatec.
Figures



Similar articles
-
Assessment of the Antibiofilm Performance of Silver-Containing Wound Dressings: A Dual-Species Biofilm Model.Cureus. 2024 Sep 24;16(9):e70086. doi: 10.7759/cureus.70086. eCollection 2024 Sep. Cureus. 2024. PMID: 39449882 Free PMC article.
-
Clinical impact of an anti-biofilm Hydrofiber dressing in hard-to-heal wounds previously managed with traditional antimicrobial products and systemic antibiotics.Burns Trauma. 2020 Mar 4;8:tkaa004. doi: 10.1093/burnst/tkaa004. eCollection 2020. Burns Trauma. 2020. PMID: 32341917 Free PMC article.
-
Evaluation of the combination of a biofilm-disrupting agent and negative pressure wound therapy: a case series.J Wound Care. 2021 Jan 2;30(1):9-14. doi: 10.12968/jowc.2021.30.1.9. J Wound Care. 2021. PMID: 33439086
-
Sucrose Octasulfate-Impregnated Dressings for Adults With Difficult-to-Heal Noninfected Diabetic Foot Ulcers and Difficult-to-Heal Noninfected Venous Leg Ulcers: A Health Technology Assessment.Ont Health Technol Assess Ser. 2024 May 8;24(4):1-101. eCollection 2024. Ont Health Technol Assess Ser. 2024. PMID: 39070301 Free PMC article.
-
Antimicrobial stewardship strategies in wound care: evidence to support the use of dialkylcarbamoyl chloride (DACC)- coated wound dressings.J Wound Care. 2021 Apr 2;30(4):284-296. doi: 10.12968/jowc.2021.30.4.284. J Wound Care. 2021. PMID: 33856907
Cited by
-
Delivery of PLGA-Loaded Influenza Vaccine Microparticles Using Dissolving Microneedles Induces a Robust Immune Response.Pharmaceutics. 2025 Apr 12;17(4):510. doi: 10.3390/pharmaceutics17040510. Pharmaceutics. 2025. PMID: 40284505 Free PMC article.
-
Antibacterial, antifungal, and antibiofilm activities of biogenic zinc nanoparticles against pathogenic microorganisms.Front Cell Infect Microbiol. 2025 Jul 14;15:1545119. doi: 10.3389/fcimb.2025.1545119. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40727704 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources